Home Privacy Archive Realtime Report

Stock Trading History of Gill Ajit

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gill Ajit since year 2005. The trader's CIK number is 1236921. At the time of this reporting, Gill Ajit is the CEO of Nektar Therapeutics (stock ticker symbol NKTR).

Stock purchases, sales, and option exercises reported by *Gill Ajit* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2006-03-23	NKTR	Nektar Therapeutics	Sale	3,545	19.61	69,517
2006-01-27	NKTR	Nektar Therapeutics	Sale	40,000	22.09	883,520
2006-01-11	NKTR	Nektar Therapeutics	Option Exercise	43,110	18.29	788,481
2005-09-09	NKTR	Nektar Therapeutics	Sale	30,000	21.17	635,100
2005-09-07	NKTR	Nektar Therapeutics	Sale	10,000	20.12	201,149

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gill Ajit (CEO of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.